Product Information

TACROLIMUS 0.03% OINTMENT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.1050 per GM under NDC 68462088165. Its NADAC has been published 164 times since Oct 4, 2023.

FDA first approved this application on Apr 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TACROLIMUS 0.03% OINTMENT

Tacrolimus
$1.1050per GM

Strength

.3 mg/g

NDC

68462088165

Classification

Generic

Dosage Form

OINTMENT

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

TACROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA210393

FDA Approved

4/16/2018

TE Code

AB

On Market Since

8/16/2023

Pharmacological Classes

Price Statistics

The NADAC for TACROLIMUS 0.03% OINTMENT has been published 164 times since Oct 4, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$1.1050 per GM
All-time high$1.5799 (Dec 13, 2023)
All-time low$0.5582 (May 22, 2024)
52-week high$1.1050
52-week low$0.7651
Median price$0.8367
Average price$0.8978
Largest weekly change+47.1% (Jan 17, 2024)
Weeks tracked164
Tracking sinceOct 4, 2023

Price History

1W

+3.3%

1M

+10.7%

3M

+22.3%

6M

+21.8%

1Y

+34.1%

3Y

-12.8%

5Y

N/A

All

-0.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TACROLIMUS 0.03% OINTMENT?

The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.1050 per GM (NDC 68462088165), effective Nov 18, 2026.

How has the price of TACROLIMUS 0.03% OINTMENT changed over time?

Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has held within roughly two percent of its current level. It has been tracked across 164 weekly CMS publications since Oct 4, 2023.

What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?

Since Oct 4, 2023, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5582 (May 22, 2024) to a high of $1.5799 (Dec 13, 2023), with a median of $0.8367 per GM.

Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.5924 per GM — about 46% below TACROLIMUS 0.03% OINTMENT.

Who manufactures TACROLIMUS 0.03% OINTMENT?

TACROLIMUS 0.03% OINTMENT (NDC 68462088165) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.